The mental health care company COMPASS Pathways reported Thursday that its its COMP350 (psilocybin) was well-tolerated by healthy volunteers …
Read the full article at: www.benzinga.com
RECENT POSTS
- Illinois dispensaries open New Year’s Day for recreational sales
- A Marijuana Dispensary Is Issuing Its Own Credit Card For Cannabis Consumers
- Lit Literature: The Best Weed Books of 2019
- Illegal marijuana crackdown
- How to Start a Cannabis or Other Legally Gray Business
- Kush in the kitchen: What to know when cooking with cannabis | Lifestyle from CTV News
- Dollar General Selling CBD Products To Mellow Out Customers
- B2B Amazon-like Platform Aims to Change Payments in Cannabis Industry
- (GRNF) – Cannabis Company Gears Up For Drone Delivery
- Why Medical Cannabis Lacks Scientific History
The post Compass Pathways Reports Positive Results From Psilocybin Study appeared first on Top Seller Website.
* This article was originally published at www.topsellers.websi www.topsellers.website
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.